Researchers have found a protein that is a critical regulator in the development of fatty liver disease in mice, according to a study published in the journal Nature Communications. Analysis of liver biopsies of patients indicate that the identified mechanisms may help explain the diverse susceptibility of patients to develop more severe stages of fatty liver disease.
Non-alcoholic fatty liver disease (NAFLD) is a condition where fat accumulates in the liver and has become the most common liver disease worldwide. While NAFLD shows few or no symptoms at initial stages, it is a potentially serious disease which can progress to an inflammatory state called steatohepatitis (NASH), which can lead to liver cirrhosis and cancer.
Fatty liver disease can be managed by weight loss, but there is currently no approved medical treatment. Thus, a better understanding of how the disease develops is critical for its prevention and treatment.
Researchers now show that a protein called GPS2 (G-protein pathway suppressor 2) is a critical regulator of lipid metabolic pathways in hepatocytes. Their results indicate that this mechanism may influence the development of the disease in both mice and in humans.
To find out the function and targets of GSP2 in hepatocytes, the researchers generated knockout mice which lack GPS2 in hepatocytes but not in other cell types. The mice were exposed to a special diet that induces the disease state NASH, and analysed with the help of clinical researchers and pathologists.
”We were surprised to find that GPS2 knockout mice were protected from developing disease”, says the lead author of the study.
The team then used sequencing-based techniques to shed light on the GPS2-dependent changes in gene expression. They identified a previously unknown role of GPS2 in specifically repressing a fatty acid receptor called PPARα. The partnership of GPS2 and PPARα was validated by an extensive physiological and histological analysis of the knockout mice.
In collaboration with clinical researchers the team analysed gene expression data from liver biopsies of patients diagnosed with different NAFLD stages. They found significant correlations of GPS2 levels with the expression of signature genes for the disease stage NASH.
”This suggests that the in mice discovered pathway might be relevant for humans as well,” says the author. “The identified mechanisms may help to explain the differential susceptibility of individual patients to develop more severe stages of fatty liver disease.”
The researchers believe that this new hepatocyte pathway could be relevant for future therapeutic strategies, but emphasize the need to know more about additional GPS2 functions in other cell types of the liver.
https://ki.se/en/news/pathway-contributing-to-fatty-liver-disease-discovered
https://www.nature.com/articles/s41467-019-09524-z
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fhepatocyte-specific&filter=22
Latest News
Microfluidic systems resemb…
By newseditor
Posted 11 May
Neurotransmitter classifica…
By newseditor
Posted 11 May
Uncovering the secret of lo…
By newseditor
Posted 10 May
A cubic-millimeter fragment…
By newseditor
Posted 10 May
mtDNA transcription Inhibit…
By newseditor
Posted 09 May
Other Top Stories
Molecular landscapes of human hippocampal immature neurons across l…
Read more
DNA recombinations are implicated in both development and disease
Read more
Molecular signatures of age-related macular degeneration
Read more
Key mechanism controlling skin regeneration
Read more
Hyaluronic acid awakens stem cells to repair damaged muscle
Read more
Protocols
Improved detection of DNA r…
By newseditor
Posted 09 May
Single-cell adhesive profil…
By newseditor
Posted 07 May
Parasympathetic neurons der…
By newseditor
Posted 07 May
Non-invasive measurements o…
By newseditor
Posted 05 May
A validation strategy to as…
By newseditor
Posted 04 May
Publications
Vascular network-inspired f…
By newseditor
Posted 11 May
Neurotransmitter classifica…
By newseditor
Posted 11 May
Forward programming human p…
By newseditor
Posted 10 May
Cyclophilin A supports tran…
By newseditor
Posted 10 May
Sortases: structure, mechan…
By newseditor
Posted 10 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar